NasdaqCM:JYNTHealthcare
Joint (JYNT) Returns To Quarterly Profit Challenging Persistent Loss Narrative
Joint (JYNT) has just posted its FY 2025 third quarter numbers, with revenue of US$13.4 million and basic EPS of US$0.02, alongside trailing twelve month revenue of US$54.2 million and a trailing EPS loss of US$0.01. Over recent quarters the company has seen quarterly revenue move from US$12.6 million in Q3 2024 to US$14.4 million in Q4 2024, then to US$13.1 million, US$13.3 million and now US$13.4 million. Basic EPS has ranged from a loss of US$0.11 in Q2 2024 to a profit of US$0.07 in Q4...